Bristol Myers Squibb (BMY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

In spite of these difficulties, the fundamental question is whether BMY's 20% decline in stock price represents a buying ...

In the most recent trading session, Bristol Myers Squibb (BMY) closed at $44.16, indicating a -1.67% shift from the previous trading day.

Bristol Myers Squibb is a strong buy, with a 5.5% yield, growth portfolio, and undervalued shares. See here for more analysis ...

Merck & Co. MRK and Bristol Myers Squibb BMY are leading drugmakers with broad and diverse portfolios and a global footprint.

Bristol Myers Squibb stock offers a relatively big yield because it recently lost exclusivity for Revlimid, a cancer therapy with sales that peaked at $12.8 billion in 2021. In a few more years, it ...

Share price of Bristol Myers Squibb (BMY) touched a 52-week low of $42.96 on July 31, post its second-quarter earnings release. The stock has recovered 6.7% since then and is currently trading at ...

Bristol-Myers Squibb Co. (NYSE:BMY) is an American multinational biopharmaceutical company that develops, manufactures, and ...

Bristol-Myers Squibb is a Strong Buy at current levels, with a $54 price target and attractive 5.2% dividend yield.